Role of neutrophil/lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease I Kocyigit, E Eroglu, A Unal, MH Sipahioglu, B Tokgoz, O Oymak, C Utas J Nephrol 26 (2), 358-65, 2013 | 115 | 2013 |
A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease I Kocyigit, MI Yilmaz, A Unal, F Ozturk, E Eroglu, C Yazici, O Orscelik, ... American journal of nephrology 38 (3), 218-225, 2013 | 42 | 2013 |
The endothelin system as target for therapeutic interventions in cardiovascular and renal disease E Eroglu, I Kocyigit, B Lindholm Clinica Chimica Acta 506, 92-106, 2020 | 39 | 2020 |
Serum uric acid levels and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease I Kocyigit, MI Yilmaz, O Orscelik, MH Sipahioglu, A Unal, E Eroglu, ... Nephron Clinical Practice 123 (3-4), 157-164, 2013 | 34 | 2013 |
Acute renal infarction in Turkey: a review of 121 cases N Eren, O Gungor, I Kocyigit, FB Guzel, E Erken, O Altunoren, E Tatar, ... International Urology and Nephrology 50, 2067-2072, 2018 | 32 | 2018 |
Serum micro-rna profiles in patients with autosomal dominant polycystic kidney disease according to hypertension and renal function I Kocyigit, S Taheri, EF Sener, E Eroglu, F Ozturk, A Unal, K Korkmaz, ... BMC nephrology 18, 1-10, 2017 | 28 | 2017 |
Pentraxin 3 as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease I Kocyigit, E Eroglu, O Orscelik, A Unal, O Gungor, F Ozturk, C Karakukcu, ... Journal of nephrology 27, 181-186, 2014 | 28 | 2014 |
Long-term protective effect of N-acetylcysteine against amikacin-induced ototoxicity in end-stage renal disease: a randomized trial A Vural, İ Koçyiğit, F Şan, E Eroğlu, I Ketenci, A Ünal, B Tokgöz, Y Ünlü Peritoneal Dialysis International 38 (1), 57-62, 2018 | 27 | 2018 |
Levofloxacin-induced delirium: is it a dangerous drug in patients with renal dysfunction? I Kocyigit, S Dortdudak, M Sipahioglu, A Unal, HE Yucel, B Tokgoz, ... Renal failure 34 (5), 634-636, 2012 | 26 | 2012 |
Evaluation of fibrosis markers: apelin and transforming growth factor‐β1 in autosomal dominant polycystic kidney disease patients D Kocer, C Karakukcu, F Ozturk, E Eroglu, I Kocyigit Therapeutic Apheresis and Dialysis 20 (5), 517-522, 2016 | 24 | 2016 |
Endothelial nitric oxide synthase gene expression is associated with hypertension in autosomal dominant polycystic kidney disease I Kocyigit, S Taheri, EF Sener, A Unal, E Eroglu, F Öztürk, K Korkmaz, ... Cardiorenal medicine 4 (3-4), 269-279, 2014 | 22 | 2014 |
The effect of periodontal disease treatment in patients with continuous ambulatory peritoneal dialysis Z Tasdemir, F Özsarı Tasdemir, C Gürgan, E Eroglu, I Gunturk, I Kocyigit International urology and nephrology 50, 1519-1528, 2018 | 18 | 2018 |
The role of platelet activation in determining response to therapy in patients with primary nephrotic syndrome I Kocyigit, MI Yilmaz, Y Şimşek, A Unal, MH Sipahioglu, E Eroglu, F Dede, ... Platelets 24 (6), 474-479, 2013 | 18 | 2013 |
Peritoneal dialysis patient selection from a comorbidity perspective E Eroglu, O Heimbürger, B Lindholm Seminars in dialysis 35 (1), 25-39, 2022 | 16 | 2022 |
The association of endothelin-1 levels with renal survival in polycystic kidney disease patients I Kocyigit, E Eroglu, AS Kaynar, D Kocer, S Kargi, G Zararsiz, R Bayramov, ... Journal of nephrology 32, 83-91, 2019 | 16 | 2019 |
A low serum free triiodothyronine level is associated with epicardial adipose tissue in peritoneal dialysis patients I Kocyigit, O Gungor, A Unal, M Yasan, O Orscelik, O Tunca, E Eroglu, ... Journal of Atherosclerosis and Thrombosis 21 (10), 1066-1074, 2014 | 16 | 2014 |
Mesangial proliferative glomerulonephritis in familial Mediterranean fever patient with E148Q mutation: the first case report E Eroglu, I Kocyigit, O Ates, A Unal, MH Sipahioglu, H Akgun, B Tokgoz, ... International urology and nephrology 45, 591-594, 2013 | 16 | 2013 |
Systemic succinate, hypoxia-inducible Factor-1 alpha, and IL-1β gene expression in autosomal dominant polycystic kidney disease with and without hypertension I Kocyigit, S Taheri, E Eroglu, EF Sener, G Zararsız, I Uzun, E Tufan, ... Cardiorenal Medicine 9 (6), 370-381, 2019 | 15 | 2019 |
The effect of Ramadan fasting on kidney function in patients with chronic kidney disease I Baloglu, K Turkmen, I Kocyigit, O Altunoren, L Demirtas, G Zararsız, ... International urology and nephrology 52, 1337-1343, 2020 | 14 | 2020 |
Association between cardiac valvular calcification and serum fetuin-A levels in renal transplant recipients I Kocyigit, A Unal, D Elcik, H Korkar, A Sen, M Yasan, E Eroglu, ... Transplantation Proceedings 47 (5), 1398-1401, 2015 | 13 | 2015 |